Onivyde, a liposomal formulation of irinotecan, is indicated for the treatment of metastatic pancreatic adenocarcinoma in combination with fluorouracil and leucovorin [1]. The list price of Onivyde can vary, but it is generally considered a high-cost medication. For example, a single 15 mL vial (70 mg/5 mL) of Onivyde may cost around $1,000, though actual out-of-pocket expenses for patients depend heavily on insurance coverage, co-pay assistance programs, and other factors [2].
How is Onivyde typically covered by insurance?
Insurance coverage for Onivyde can be complex. Many insurance plans require prior authorization before approving coverage for the drug [3]. Patients may also face significant co-pays or deductibles, even with insurance. Manufacturers often provide financial assistance programs to help eligible patients afford the medication [2, 3].
What financial assistance programs are available for Onivyde?
Ipsen Biopharmaceuticals, the manufacturer of Onivyde, offers patient assistance programs. These programs can provide co-pay support for commercially insured patients or free medication for eligible uninsured patients [2, 3]. Details and eligibility criteria for these programs are available through the manufacturer's website or by contacting their patient support services.
How does the cost of Onivyde compare to other pancreatic cancer treatments?
Onivyde is one of several treatment options for pancreatic cancer, and its cost is comparable to other targeted therapies and biologics used in oncology. The decision to use Onivyde is typically based on clinical efficacy, patient suitability, and treatment guidelines, rather than solely on cost [1]. The overall cost of cancer care also includes associated medical services, hospitalizations, and supportive care, which can be substantial regardless of the specific drug used.
When does Onivyde's patent exclusivity end?
Patent protection for Onivyde is a critical factor in its market exclusivity and eventual generic competition. Information on specific patent expiry dates for Onivyde and its associated formulations can be found through resources like DrugPatentWatch.com [4]. Patent expiry allows for the development and approval of biosimilar or generic versions of the drug, which can lead to lower prices.